
Sergio Coffa
Examiner (ID: 56, Phone: (571)270-3022 , Office: P/1675 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1676, 1658, 1675 |
| Total Applications | 903 |
| Issued Applications | 444 |
| Pending Applications | 134 |
| Abandoned Applications | 351 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9162045
[patent_doc_number] => 20130310322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'ISOLATED EXTRACELLULAR MATRIX MATERIAL INCLUDING SUBSEROUS FASCIA'
[patent_app_type] => utility
[patent_app_number] => 13/951631
[patent_app_country] => US
[patent_app_date] => 2013-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12078
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13951631
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/951631 | Isolated extracellular matrix material including subserous fascia | Jul 25, 2013 | Issued |
Array
(
[id] => 11814923
[patent_doc_number] => 09718865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Sodium channel blocking peptides and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/417394
[patent_app_country] => US
[patent_app_date] => 2013-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15824
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417394
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/417394 | Sodium channel blocking peptides and the use thereof | Jul 25, 2013 | Issued |
Array
(
[id] => 10452013
[patent_doc_number] => 20150337026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'PEPTIDE-BASED COMPOUNDS AND USES THEREOF TO TREAT BETA-AMYLOID ACCUMULATION'
[patent_app_type] => utility
[patent_app_number] => 14/416956
[patent_app_country] => US
[patent_app_date] => 2013-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16482
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416956
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/416956 | Peptide-based compounds and uses thereof to treat beta-amyloid accumulation | Jul 23, 2013 | Issued |
Array
(
[id] => 9160915
[patent_doc_number] => 20130309192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'Auristatin Compounds and Conjugates Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/944561
[patent_app_country] => US
[patent_app_date] => 2013-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 54290
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13944561
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/944561 | Auristatin compounds and conjugates thereof | Jul 16, 2013 | Issued |
Array
(
[id] => 12302640
[patent_doc_number] => 09937235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => Lipidated peptides as anti-obesity agents
[patent_app_type] => utility
[patent_app_number] => 14/414034
[patent_app_country] => US
[patent_app_date] => 2013-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 11990
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14414034
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/414034 | Lipidated peptides as anti-obesity agents | Jul 10, 2013 | Issued |
Array
(
[id] => 9205937
[patent_doc_number] => 20140005114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/926766
[patent_app_country] => US
[patent_app_date] => 2013-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19510
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13926766
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/926766 | β-arrestin effectors and compositions and methods of use thereof | Jun 24, 2013 | Issued |
Array
(
[id] => 9662283
[patent_doc_number] => 08809260
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-19
[patent_title] => 'β-arrestin effectors and compositions and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/925170
[patent_app_country] => US
[patent_app_date] => 2013-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19276
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13925170
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/925170 | β-arrestin effectors and compositions and methods of use thereof | Jun 23, 2013 | Issued |
Array
(
[id] => 9205920
[patent_doc_number] => 20140005097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'BIOACTIVE PEPTIDES AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/923690
[patent_app_country] => US
[patent_app_date] => 2013-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 36530
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13923690
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/923690 | Bioactive peptides and methods of using same | Jun 20, 2013 | Issued |
Array
(
[id] => 10566345
[patent_doc_number] => 09289496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-22
[patent_title] => 'Lipid dipeptide and gel'
[patent_app_type] => utility
[patent_app_number] => 13/911500
[patent_app_country] => US
[patent_app_date] => 2013-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 20851
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13911500
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/911500 | Lipid dipeptide and gel | Jun 5, 2013 | Issued |
Array
(
[id] => 9082080
[patent_doc_number] => 20130267610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'NOVEL LIPID DIPEPTIDE AND GEL'
[patent_app_type] => utility
[patent_app_number] => 13/911533
[patent_app_country] => US
[patent_app_date] => 2013-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20860
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13911533
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/911533 | NOVEL LIPID DIPEPTIDE AND GEL | Jun 5, 2013 | Abandoned |
Array
(
[id] => 10333212
[patent_doc_number] => 20150218215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'CLADOSPORIUM PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/403462
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16592
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403462
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/403462 | Cladosporium peptides | May 29, 2013 | Issued |
Array
(
[id] => 10317312
[patent_doc_number] => 20150202314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-23
[patent_title] => 'SITE-SPECIFIC LABELING AND TARGETED DELIVERY OF PROTEINS FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/400190
[patent_app_country] => US
[patent_app_date] => 2013-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22549
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14400190
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/400190 | Site-specific labeling and targeted delivery of proteins for the treatment of cancer | May 12, 2013 | Issued |
Array
(
[id] => 11843444
[patent_doc_number] => 09730984
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Composition for preventing or treating rheumatoid arthritis'
[patent_app_type] => utility
[patent_app_number] => 14/400324
[patent_app_country] => US
[patent_app_date] => 2013-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7460
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14400324
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/400324 | Composition for preventing or treating rheumatoid arthritis | May 9, 2013 | Issued |
Array
(
[id] => 10306763
[patent_doc_number] => 20150191763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'COMPOSITIONS FOR IN SITU LABELING OF BACTERIAL CELL WALLS WITH FLUOROPHORES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/395815
[patent_app_country] => US
[patent_app_date] => 2013-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12861
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395815
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/395815 | COMPOSITIONS FOR IN SITU LABELING OF BACTERIAL CELL WALLS WITH FLUOROPHORES AND METHODS OF USE THEREOF | Apr 20, 2013 | Abandoned |
Array
(
[id] => 9435465
[patent_doc_number] => 20140113372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-24
[patent_title] => 'CELL CULTURE SUBSTRATE, AND CELL CULTURING METHOD USING THE SUBSTRATE AND METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS USING THE SUBSTRATE'
[patent_app_type] => utility
[patent_app_number] => 13/865642
[patent_app_country] => US
[patent_app_date] => 2013-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20201
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13865642
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/865642 | Cell culture substrate, and cell culturing method using the substrate and method for inducing differentiation of pluripotent stem cells using the substrate | Apr 17, 2013 | Issued |
Array
(
[id] => 9268674
[patent_doc_number] => 20140023591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'HETEROMULTIVALENT NANOPARTICLE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/863005
[patent_app_country] => US
[patent_app_date] => 2013-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 22519
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13863005
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/863005 | Heteromultivalent nanoparticle compositions | Apr 14, 2013 | Issued |
Array
(
[id] => 10397470
[patent_doc_number] => 20150282477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'METHOD FOR TREATING BLOOD, BLOOD PRODUCTS AND ORGANS'
[patent_app_type] => utility
[patent_app_number] => 14/388865
[patent_app_country] => US
[patent_app_date] => 2013-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11267
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388865
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/388865 | Method for treating blood, blood products and organs | Apr 4, 2013 | Issued |
Array
(
[id] => 11463852
[patent_doc_number] => 09580470
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'High-purity cyclopeptide crystal as well as preparation method and use thereof'
[patent_app_type] => utility
[patent_app_number] => 14/389352
[patent_app_country] => US
[patent_app_date] => 2013-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 15610
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389352
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389352 | High-purity cyclopeptide crystal as well as preparation method and use thereof | Mar 28, 2013 | Issued |
Array
(
[id] => 10714144
[patent_doc_number] => 20160060291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'PROCESS FOR RENATURATION OF POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/388892
[patent_app_country] => US
[patent_app_date] => 2013-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6974
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388892
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/388892 | PROCESS FOR RENATURATION OF POLYPEPTIDES | Mar 27, 2013 | Abandoned |
Array
(
[id] => 9093713
[patent_doc_number] => 20130273024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-17
[patent_title] => 'METHODS FOR TREATING ATHEROSCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 13/851019
[patent_app_country] => US
[patent_app_date] => 2013-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24685
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13851019
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/851019 | METHODS FOR TREATING ATHEROSCLEROSIS | Mar 25, 2013 | Abandoned |